US charitable investments
Be a Health Scientist! Science in the Summer™
The 2025 GSK Science in the Summer™ curriculum gives students the chance to become real scientists and engineers through hands-on activities that explore health science careers, solve real-world problems, and build essential STEM skills for future success. From athletic trainers to epidemiologists, students will discover exciting career paths, grow their curiosity, and learn just how fun and inspiring science can be.
Investors
We announced our quarter 1 2025 results on Wednesday, April 30th.
Press releases
- GSK provides update on US FDA advisory committee review of Blenrep (belantamab mafodotin-blmf) combinations for patients with relapsed/refractory multiple myeloma
- US FDA approves GSK’s SHINGRIX in a prefilled syringe presentation
- US FDA accepts application to review expanded use of GSK’s RSV vaccine, Arexvy, for adults 18-49 at increased risk
GSK Global links
Visit our Global site for additional features